By Nerac IP Analysts
Originally Published July 28, 2020
Changing industry demands and new business challenges are also offering unprecedented opportunity. This sample research report demonstrates our approach for a client looking to expand into a new market by acquiring a start-up or licensing existing IP. Read more here.
Functional Foods and Future Disruptions – Sample Research Report
By Helga Weires, Nerac Analyst
Originally published July 16, 2020
Identifying emerging technologies and future disruptions: What does that look like? How can it help you? Let’s look at a sample Nerac research report. Read more here.
Impact of COVID-19 on the Disinfectant and PPE Supply Chain – Sample Research Report
Originally published June 12, 2020
This Sample Research Report explores the dynamic supply chain changes and disruptive technologies evolving in this market, and provides analysis and recommendations for adjacent market opportunities, avoiding future supply chain disruption as well as improving market position. Get the report here.
Competitive Intelligence Briefing – Sample Research Report
By Rosemarie Szostak, Ph.D., Nerac Analyst
Originally published April 23, 2020
Competitive Intelligence (CI) is not about more information, but rather facilitating a company’s agility in the marketplace. This sample CI Briefing looks at the sustainable packaging marketplace and explores competitive intelligence, and its power in more detail. Get the report here.
Sample Report – Technical File Review
By Ron Sills, M.S., Nerac Analyst
Originally Published: April 7, 2014
A medical device company has requested that Nerac perform a pre-assessment audit of their debridement devices, which are a Class IIb product family, to assess compliance with the essential requirements of the Medical Devices Directive 93/42/EEC 2007, Annex IX, and with the company’s quality management system (QMS) certification per EN ISO 13485:2012.
This sample report demonstrates the findings of the review.
Read More
Which is Better, Sugar or Artificial Sweetener?
By Stephen E. Buxser, Ph.D., Nerac Analyst,
Originally Published: October 31st, 2014
Which is better, sugar or artificial sweetener? Or put another way… “regular” or “diet”?
Read more
Clinical Literature Evaluations via an Objective Third Party Reviewer: Maintaining Compliance with the EU Medical Directives and Beyond
By Ron Sills & Donna Mitchell-Magaldi, Nerac Analysts
Originally Published: September 26th, 2014
Our medical device team is at the Regulatory Affairs Professionals Society conference in Austin, TX and early reports are that the EU will be pushing hard on Notified Bodies to increase the demands on Medical Device Regulatory Affairs submissions. As a result, we feel that auditors will be much more critical in their inspection, so it is imperative that you keep your clinical literature evaluations and updates current.
We invite you to download our free white paper “Clinical Literature Evaluations via an Objective Third Party Reviewer: Maintaining Compliance with the EU Medical Directives and Beyond” to learn more about how we can help. Read more
New Diagnostics in Medicine – Cheap, Fast, and Accurate
By Stephen Buxser, Ph.D.
Originally Published: July 15, 2014
A major, if not the major, driver of advances in medicine is the development of better diagnostics. Read more
New Perspectives on the Future of Drug Discovery
Originally Published: April, 2008
In many industries, innovation is generally recognized as a critical ingredient for corporate success. Read more
Scouting for Innovation: Global Benchmarking Study
Originally published September, 2009
In many industries, innovation is generally recognized as a critical ingredient for corporate success.
Read more